Annett Boeddrich

Title: Annett Boeddrich: Innovator in Neurodegenerative Disease Research

Introduction

Annett Boeddrich is a notable inventor based in Falkensee, Germany. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented inventions. Her work focuses on the modulation of protein misfolding and aggregation, which are critical factors in the development of various neurodegenerative disorders.

Latest Patents

Annett Boeddrich holds 2 patents that reflect her expertise in the field. Her latest patents include:

1. Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates. This invention relates to compounds that serve as modulators of protein misfolding and aggregation, particularly as inhibitors of amyloid aggregate formation.

2. Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases. This patent encompasses pharmaceutical and diagnostic compositions aimed at treating or diagnosing neurodegenerative disorders.

Career Highlights

Throughout her career, Annett has worked with esteemed institutions such as the Max Delbrück Center for Molecular Medicine. Her research has been pivotal in advancing our understanding of amyloid diseases and developing potential therapeutic strategies.

Collaborations

Annett has collaborated with notable colleagues, including Erich Wanker and Susanne Rautenberg, who have contributed to her research endeavors.

Conclusion

Annett Boeddrich's innovative work in the field of neurodegenerative diseases highlights her commitment to advancing medical science. Her patents and collaborations reflect her significant impact on the research community.